vidarabine has been researched along with Transfusion Reaction in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyraz, MS; Çağdaş, D; Güçer, Ş; Tezcan, İ; Uçkan Çetinkaya, D; Ünal, Ş | 1 |
| Hoffman, PC | 1 |
| Blumberg, N; Fenton, P; Horan, JT; Liesveld, JL; Walters, MC | 1 |
| Andreani, M; Gaziev, J; Lucarelli, G; Polchi, P; Sodani, P | 1 |
| Cutler, FJ; Murphy, JA; Niciu, C; Soutar, RL | 1 |
| Appleton, AL; Hamilton, PJ; Jackson, GH; Maung, ZT; Turner, GE; Wood, AC | 1 |
| Algora, M; Briz, M; Cabrera, R; Díez, JL; Fernández, MN; Forés, R; Herrero, M; Regidor, C; Sanjuán, I | 1 |
| Alcorta, I; Briones, J; Pereira, A | 1 |
| Williamson, LM; Wimperis, JZ; Wood, ME; Woodcock, B | 1 |
| Alcala, A; Arias-Sampedro, J; Bosch, F; Fernandez, MN; Garcia-Conde, J; Guardia, R; Lopez-Lorenzo, JL; Manso, F; Martin, A; Montserrat, E; Odriozola, J; Oyarzabal, FJ; Prieto, E | 1 |
| Cummins, M; Deane, M; Emery, V; Gor, D; Griffith, PD; Macmahon, ME; Prentice, HG | 1 |
| Bacigalupo, A; Endo, T; Fujimoto, K; Koike, T; Nakao, S; Nishio, M; Sakai, T; Sawada, K; Takashima, H | 1 |
1 review(s) available for vidarabine and Transfusion Reaction
| Article | Year |
|---|---|
Immune hemolytic anemia--selected topics.
Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Blood Group Incompatibility; Cladribine; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lymphocyte Subsets; Lymphoproliferative Disorders; Postoperative Complications; Rituximab; Splenectomy; Transfusion Reaction; Transplantation; Transplantation, Homologous; Venous Thromboembolism; Vidarabine | 2009 |
1 trial(s) available for vidarabine and Transfusion Reaction
| Article | Year |
|---|---|
Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Antilymphocyte Serum; Child; Combined Modality Therapy; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinopathies; Humans; Immunosuppressive Agents; Infections; Male; Pancytopenia; Thalassemia; Transfusion Reaction; Transplantation Chimera; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
10 other study(ies) available for vidarabine and Transfusion Reaction
| Article | Year |
|---|---|
Diagnosis: Melanoderma after Hematopoietic Stem Cell Transplantation.
Topics: Antilymphocyte Serum; Busulfan; Deferoxamine; Diagnosis, Differential; Ecchymosis; Humans; Infant; Iron Overload; Male; Melanosis; Peripheral Blood Stem Cell Transplantation; Severe Combined Immunodeficiency; Transfusion Reaction; Transplantation Conditioning; Vidarabine | 2015 |
Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
Topics: Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Busulfan; Chelation Therapy; Clinical Protocols; Combined Modality Therapy; Comorbidity; Deferoxamine; Disease-Free Survival; Erythrocyte Transfusion; Erythropoietin; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Cell Growth Factors; Hemosiderosis; Humans; Hydroxyurea; Immunosuppressive Agents; Iron Chelating Agents; Life Tables; Liver Cirrhosis; Male; Phlebotomy; Postoperative Complications; Survival Analysis; Thalassemia; Transfusion Reaction; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2005 |
Use of TAGVHD warnings in patients receiving purine analogue chemotherapy.
Topics: Blood Transfusion; Enzyme Inhibitors; Graft vs Host Disease; Health Policy; Humans; Retrospective Studies; Risk Factors; Transfusion Reaction; Vidarabine | 2008 |
Transfusion-associated graft-versus-host disease in fludarabine-treated B-chronic lymphocytic leukaemia.
Topics: Antineoplastic Agents; Graft vs Host Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Transfusion Reaction; Vidarabine | 1994 |
Diagnosis of transfusion-associated graft-versus-host disease by polymerase chain reaction in fludarabine-treated B-chronic lymphocytic leukaemia.
Topics: Antineoplastic Agents; Female; Graft vs Host Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Polymerase Chain Reaction; Transfusion Reaction; Vidarabine | 1995 |
Transfusion-associated graft-versus-host disease (TA-GVHD) in fludarabine-treated patients: is it time to irradiate blood component?
Topics: Antineoplastic Agents; Graft vs Host Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Transfusion Reaction; Vidarabine | 1996 |
Fludarabine treatment and transfusion-associated graft-versus-host disease.
Topics: Antineoplastic Agents; Fatal Outcome; Female; Graft vs Host Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Transfusion Reaction; Vidarabine | 1996 |
Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience.
Topics: Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Cause of Death; Drug Evaluation; Fever; Graft vs Host Disease; Hematologic Diseases; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Life Tables; Remission Induction; Retrospective Studies; Salvage Therapy; Spain; Survival Analysis; Transfusion Reaction; Treatment Outcome; Vidarabine | 1996 |
Quantification of CMV viraemia in a case of transfusion-related graft-versus-host disease associated with purine analogue treatment.
Topics: Acute Disease; Adult; Antineoplastic Agents; Cytomegalovirus Infections; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Leukemia, Myeloid; Lymphopenia; T-Lymphocytes; Transfusion Reaction; Vidarabine; Viremia | 1997 |
Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure.
Topics: Adult; Anabolic Agents; Anemia, Aplastic; Antilymphocyte Serum; Combined Modality Therapy; Cyclosporine; Diabetes Complications; Female; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Iron Overload; Methylprednisolone; T-Lymphocytes; Transfusion Reaction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2001 |